Knockdown of CRM1 inhibits the nuclear export of p27Kip1 phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer-Reference-Cited by-同舟云学术

Knockdown of CRM1 inhibits the nuclear export of p27Kip1 phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer

Published:2014-02 Issue:1 Volume:343 Page:6-13
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wang You,Wang Yingying,Xiang Jingying,Ji Fang,Deng Yan,Tang Chunhui,Yang Shuyun,Xi Qinghua,Liu Rong,Di Wen

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Cancer statistics;Jemal;CA Cancer J. Clin.,2010

2. Overexpression of PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer;Bao;J. Histochem. Cytochem.,2013

3. Effect of Xpcl1 activation and p27(Kip1) loss on gene expression in murine lymphoma;Kuppers;PLoS ONE,2011

4. Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization;Viglietto;Cell Cycle,2002

5. Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer;Sgambato;Mol. Carcinogen.,1999

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological and prognostic significance of XPO1 in solid tumors: meta-analysis and TCGA analysis;Expert Review of Molecular Diagnostics;2023-06-19

2. Knockdown of UBE2I inhibits tumorigenesis and enhances chemosensitivity of cholangiocarcinoma via modulating p27kip1 nuclear export;Molecular Carcinogenesis;2023-02-24

3. RNF4 promotes tumorigenesis, therapy resistance of cholangiocarcinoma and affects cell cycle by regulating the ubiquitination degradation of p27kip1 in the nucleus;Experimental Cell Research;2022-10

4. Differential regulation of p27Kip1 depending on culture conditions and its correlation with status of p14ARF and p53;Genes to Cells;2022-01-17

5. Chromosome Region Maintenance 1 (XPO1/CRM1) as an Anticancer Target and Discovery of Its Inhibitor;Journal of Medicinal Chemistry;2021-10-20